Strategic workshops on cancer nanotechnology.
Nanotechnology offers the potential for new approaches to detecting, treating, and preventing cancer. To determine the current status of the cancer nanotechnology field and the optimal path forward, the National Cancer Institute's Alliance for Nanotechnology in Cancer held three strategic workshops, covering the areas of in vitro diagnostics and prevention, therapy and post-treatment, and in vivo diagnosis and imaging. At each of these meetings, a wide range of experts from academia, industry, the nonprofit sector, and the U.S. government discussed opportunities in the field of cancer nanotechnology and barriers to its implementation.
Nagahara
Larry A
LA
Center for Strategic Scientific Initiatives, National Cancer Institute, Bethesda, Maryland 20892, USA.
Lee
Jerry S H
JS
Molnar
Linda K
LK
Panaro
Nicholas J
NJ
Farrell
Dorothy
D
Ptak
Krzysztof
K
Alper
Joseph
J
Grodzinski
Piotr
P
D000818:Animals; D006801:Humans; D036103:Nanotechnology / Q000379:methods*; D009369:Neoplasms / Q000175:diagnosis* / Q000628:therapy*
Biosens Bioelectron. 2009 Jul 15;24(11):3252-7
19442510
Nat Nanotechnol. 2010 Feb;5(2):160-5
20023645
Science. 2005 Dec 16;310(5755):1793-6
16357255
Acc Chem Res. 2008 Dec;41(12):1842-51
19053240
Angew Chem Int Ed Engl. 2009;48(27):4944-8
19301344
Proc Am Thorac Soc. 2009 Aug 15;6(5):411-5
19687212
J Control Release. 2007 Aug 16;121(1-2):10-8
17643544
Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18437-42
19841273
Nat Med. 2002 Feb;8(2):121-7
11821895